Vaxart Inc (VXRT)
$7.18
0.16 (2.18%)
19:59 EST
VXRT Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
51.27M
PE Ratio
-1.31
EPS
-5.500006
Volume (Avg. Vol.)
9.18M
Day's Range
6.95 - 7.74
52-Week Range
0.37 - 17.49
Dividend & Yield
N/A (N/A)
VXRT Stock Predictions, Articles, and Vaxart Inc News
- From InvestorPlace
- From the Web
VXRT Stock News: Vaxart Shares Surge on Promising COVID-19 Vaccine News
Vaxart (VXRT) is getting a boost to VXRT stock on Thursday after releasing positive news concerning its vaccine for the novel coronavirus.
7 Biotech Penny Stocks Worth a Gamble
With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved.
Vaxart News: Why VXRT Stock Is Under Fire Today
Vaxart (VXRT) news for Monday isn't good as the company faces a federal investigation and lawsuits over its coronavirus claims.
The Small-Cap Tech Stocks Tripping My Moneyball ‘Buy’ Alerts
Louis Navellier zeroes in on eventual stock winners, spots their key momentum levers, and allows smart folks to learn how to get positioned months or even years before the mainstream media finally catches on.
Trump Coronavirus News: Why the Market Is Sliding Today
The market is sliding on today on Trump coronavirus news following confirmation that President Donald Trump tested positive.
3 Small-Cap Stocks To Buy For Large Cap Potential
By
Ian Cooper
It doesn’t matter who wins the U.S. election, because small cap stocks should outperform either way over renewed focus on domestic issues.
VXRT Stock: Vaxart Shoots Higher on Human Trial Approval
Vaxart just announced it will begin enrolling participants in human trials of its coronavirus vaccine. VXRT stock is popping in response.
4 Catalysts Could Drive Inovio Pharmaceuticals Stock to Near-term Highs
By
Ian Cooper
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
5 Stocks to Buy That Are Holding Strong While Everything Else Crumbles
Unlike the broader market, these stocks to buy have managed to hold up strong amid the ongoing public health crisis.
Vaxart’s Flu Vaccine Looks Promising, But Its Future Is Uncertain
VXRT soared last week on favorable data. The company is developing a vaccine for the flu. And while the vaccine could be a game changer, VXRT stock still poses notable risks.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
Buy